Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors
PaperCitations, authors & open-access status
A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 236 citations, 2017 year and closed oa status.
236
Citations
2017
Year
closed
OA Status